| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.7M | -42.6% |
| Cost of Revenue | $9.0M | -22.2% |
| Gross Profit | $665K | -87.4% |
| R&D Expense | $743K | -67.6% |
| SG&A Expense | $12.3M | -23.4% |
| Operating Income | -$10.2M | +46.2% |
| Interest Expense | $100K | — |
| Pre-tax Income | -$28.4M | -52.0% |
| Income Tax | -$2K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.2M | +7148.8% |
| Accounts Receivable | $348K | -69.7% |
| Inventory | $1.6M | -91.7% |
| Current Assets | $34.7M | +44.5% |
| Total Assets | $54.0M | +19.3% |
| Current Liabilities | $24.7M | -40.2% |
| Long-term Debt | $10.5M | -34.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.6M | +62.6% |
| Capital Expenditures | $4K | -93.2% |
| Investing Cash Flow | -$54K | -100.2% |
| Financing Cash Flow | $42.4M | +1102.4% |
| Free Cash Flow | -$11.6M | +62.7% |
| -200.0% |
| Net Income | -$41.7M | -123.9% |
| EPS (Basic) | -$40.92 | -227.1% |
| EPS (Diluted) | -$40.92 | -227.1% |
| Total Liabilities |
| $25.9M |
| -56.8% |
| Stockholders' Equity | $27.9M | +286.5% |